Metro Brands Limited (BOM:543426)

Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	301,589	275,871	313,775	215,933	166,217	-
Market Cap Growth	-6.25%	-12.08%	45.31%	29.91%	-	-
Enterprise Value	307,844	276,971	317,598	216,412	167,286	-
Last Close Price	1108.00	1012.25	1130.04	777.25	603.91	-
PE Ratio	84.39	78.68	76.07	59.74	78.56	-
PS Ratio	11.78	11.00	13.31	10.15	12.38	-
PB Ratio	17.35	15.87	16.58	13.72	12.91	-
P/TBV Ratio	19.52	17.86	18.46	15.65	13.18	-
P/FCF Ratio	-	45.22	66.20	76.84	96.76	-
P/OCF Ratio	-	39.55	53.18	56.72	75.66	-
EV/Sales Ratio	12.03	11.05	13.48	10.17	12.46	-
EV/EBITDA Ratio	37.78	36.57	59.67	39.88	54.39	-
EV/EBIT Ratio	60.79	55.46	66.72	43.29	60.03	-
EV/FCF Ratio	-	45.40	67.01	77.01	97.38	-
Debt / Equity Ratio	0.71	0.71	0.58	0.60	0.54	0.67
Debt / EBITDA Ratio	1.51	1.62	1.56	1.39	1.68	3.26
Debt / FCF Ratio	-	2.01	2.32	3.36	4.03	2.36
Asset Turnover	-	0.75	0.75	0.82	0.68	0.49
Inventory Turnover	-	1.58	1.46	1.67	1.59	1.08
Quick Ratio	-	1.33	1.84	1.51	2.01	1.65
Current Ratio	-	2.90	3.34	2.92	3.24	2.66
Return on Equity (ROE)	-	19.52%	23.96%	25.54%	20.07%	7.70%
Return on Assets (ROA)	-	9.34%	9.51%	11.99%	8.79%	2.04%
Return on Capital (ROIC)	10.58%	10.48%	10.80%	13.90%	10.27%	2.40%
Return on Capital Employed (ROCE)	-	17.90%	16.70%	20.90%	14.80%	4.00%
Earnings Yield	1.19%	1.27%	1.31%	1.67%	1.27%	-
FCF Yield	-	2.21%	1.51%	1.30%	1.03%	-
Dividend Yield	1.67%	0.54%	0.44%	0.52%	0.37%	-
Payout Ratio	-	154.58%	28.01%	24.43%	33.37%	73.00%
Buyback Yield / Dilution	-0.01%	-0.05%	-0.09%	-1.55%	-1.09%	0.01%
Total Shareholder Return	1.65%	0.50%	0.35%	-1.04%	-0.72%	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.